Cargando…
Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid
INTRODUCTION: Because tumor-associated inflammation is a hallmark of cancer treatment, in the present study, sorafenib mesoporous silica nanomatrix (MSNM@SFN) co-administrated with flufenamic acid (FFA, a non-steroidal anti–inflammatory drug (NSAID)) was investigated to enhance the anti-tumor activi...
Autores principales: | Li, Zhuo-Yue, Yin, Yi-Fan, Guo, Yang, Li, Hui, Xu, Mei-Qi, Liu, Man, Wang, Jing-Ru, Feng, Zhen-Han, Duan, Xiao-Chuan, Zhang, Shuang, Zhang, Shuai-Qiang, Wang, Guang-Xue, Liao, Ai, Wang, Shu-Min, Zhang, Xuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083629/ https://www.ncbi.nlm.nih.gov/pubmed/32214813 http://dx.doi.org/10.2147/IJN.S240436 |
Ejemplares similares
-
Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix
por: Guo, Yang, et al.
Publicado: (2017) -
A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1
por: Qu, Wei, et al.
Publicado: (2012) -
Polymorphic transitions in flufenamic acid-trehalose composites
por: Pang, Yuying, et al.
Publicado: (2023) -
Transition Metal Complexes with Flufenamic Acid for Pharmaceutical Applications—A Novel Three-Centered Coordination Polymer of Mn(II) Flufenamate
por: Gacki, Michał, et al.
Publicado: (2020) -
Ultrasound-Responsive Biomimetic Superhydrophobic Drug-Loaded Mesoporous Silica Nanoparticles for Treating Prostate Tumor
por: Jin, Qiaofeng, et al.
Publicado: (2023)